BIO26 Healthcare Special Address
NVIDIA released a new toolkit called BioNeMo Agent Toolkit that's meant to let AI agents actually do hands-on scientific work in biology and chemistry - not just answer questions about it. Instead of an AI just chatting about a protein or a drug compound, it can now use real scientific software tools: predicting protein shapes, testing how well a drug molecule binds to a target, analyzing genetic sequencing data, and suggesting which lab experiments to try next.
Companies including Dassault Systèmes, Databricks, Eli Lilly, Schrödinger, Snowflake, and the University of Washington's Institute for Protein Design are adopting it, and both Anthropic and OpenAI are integrating it into their systems. The idea is that a general AI chatbot is bad at knowing which specialized scientific tool to use for a given task - this toolkit hands it the right tools and know-how so it can work more like a research assistant.
Press Release https://nvda.ws/4g0tPyf
Tech Blog https://nvda.ws/4uS6x1c
Follow us:
X: https://nvda.ws/4hi2sxB
LinkedIn: https://nvda.ws/4eSlE3B
Subscribe to the NVIDIA AI Healthcare Newsletter: https://nvda.ws/4eS1F54
Our CEO Jensen Huang and @Dell Chairman & CEO @MichaelDell kicked things off at #DellTechWorld in Vegas with a look at how the Dell AI Factory with NVIDIA is redefining how companies build, run, and scale AI. We saw NemoClaw powering agentic AI on-prem, robots demonstrating #physicalAI in the real world, and sessions packed with enterprise use cases.
RT @valaratomics: Today, Valar Atomics became the first nuclear startup to make electricity, and we did it by powering an NVIDIA Spark. Th…
A decade after NVIDIA DGX-1, NVIDIA Vera Rubin redefines what an AI factory looks like. Built through extreme co-design, Vera Rubin delivers a POD-scale platform for manufacturing, cloud, and infrastructure partners that is purpose-built for global-scale AI infrastructure. From model training to agentic AI workloads, Vera Rubin is the foundation for what comes next. #NVIDIAVeraRubin #ISC26 🔗 nvda.ws/4dA9VXR
BIO26 Healthcare Special Address
NVIDIA released a new toolkit called BioNeMo Agent Toolkit that's meant to let AI agents actually do hands-on scientific work in biology and chemistry - not just answer questions about it. Instead of an AI just chatting about a protein or a drug compound, it can now use real scientific software tools: predicting protein shapes, testing how well a drug molecule binds to a target, analyzing genetic sequencing data, and suggesting which lab experiments to try next. Companies including Dassault Systèmes, Databricks, Eli Lilly, Schrödinger, Snowflake, and the University of Washington's Institute for Protein Design are adopting it, and both Anthropic and OpenAI are integrating it into their systems. The idea is that a general AI chatbot is bad at knowing which specialized scientific tool to use for a given task - this toolkit hands it the right tools and know-how so it can work more like a research assistant. Press Release https://nvda.ws/4g0tPyf Tech Blog https://nvda.ws/4uS6x1c Follow us: X: https://nvda.ws/4hi2sxB LinkedIn: https://nvda.ws/4eSlE3B Subscribe to the NVIDIA AI Healthcare Newsletter: https://nvda.ws/4eS1F54